CORMEDIX INC. - COMMON STOCK

CorMedix Inc. Announces New Commercial Agreement

19 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

13 سبتمبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

09 سبتمبر 2024 10:52:30 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

14 أغسطس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

07 أغسطس 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces Outpatient Availability of DefenCath

03 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

18 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

06 يونيو 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

10 مايو 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

09 مايو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

06 مايو 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

19 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)

15 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference

11 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC

08 أبريل 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Needham Annual Healthcare Conference

27 مارس 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

12 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024

06 مارس 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Reimbursement Updates

30 يناير 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Operational Updates

08 يناير 2024 08:30:00 بحسب Nasdaq GlobeNewswire